<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM2004116-17</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-7855</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Эпидемиология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Epidemiology</subject></subj-group></article-categories><title-group><article-title>Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION)</article-title><trans-title-group xml:lang="en"><trans-title>The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8175-7886</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дедов</surname><given-names>Иван Иванович</given-names></name><name name-style="western" xml:lang="en"><surname>Dedov</surname><given-names>Ivan I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>академик РАН, директор, ФГБУ Эндокринологический научный центр, Москва, Российская Федерация</p></bio><bio xml:lang="en"><p>MD, PhD, Professor, Vice-president of Russian Academy of Sciences</p></bio><email xlink:type="simple">galstyangagik964@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестакова</surname><given-names>Марина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Shestakova</surname><given-names>Marina V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>член-корр. РАН, директор Института диабета, ФГБУ Эндокринологический научный центр; зав. кафедрой эндокринологии и диабетологии педиатрического факультета Первого МГМУ им. И.М.Сеченова, Москва, Российская Федерация</p></bio><bio xml:lang="en"><p>MD, PhD, Professor, correspondence fellow of Russian Academy of Sciences</p></bio><email xlink:type="simple">galstyangagik964@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галстян</surname><given-names>Гагик Радикович</given-names></name><name name-style="western" xml:lang="en"><surname>Galstyan</surname><given-names>Gagik R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зав. отделением диабетической стопы, ФГБУ Эндокринологический научный центр; профессор кафедры эндокринологии и диабетологии педиатрического факультета Первого МГМУ им. И.М.Сеченова, Москва, Российская Федерация</p></bio><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><email xlink:type="simple">galstyangagik964@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Эндокринологический научный центр» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Эндокринологический научный центр» Минздрава России; &#13;
ГБОУ ВПО "Первый Московский государственный медицинский университет им. И.М.Сеченова"</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre, Moscow; I.M. Sechenov First Moscow State Medical University, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ "Эндокринологический научный центр" Минздрава России; &#13;
ГБОУ ВПО "Первый Московский государственный медицинский университет им. И.М.Сеченова"</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre, Moscow; I.M. Sechenov First Moscow State Medical University, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>04</day><month>04</month><year>2016</year></pub-date><volume>19</volume><issue>2</issue><fpage>104</fpage><lpage>112</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дедов И.И., Шестакова М.В., Галстян Г.Р., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Дедов И.И., Шестакова М.В., Галстян Г.Р.</copyright-holder><copyright-holder xml:lang="en">Dedov I.I., Shestakova M.V., Galstyan G.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/7855">https://www.dia-endojournals.ru/jour/article/view/7855</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценка распространенности сахарного диабета 2 типа (СД2) у взрослого населения России.</p></sec><sec><title>Методы</title><p>Методы. NATION – это первое национальное эпидемиологическое кросс-секционное исследование, проведенное на территории Российской Федерации по выявлению распространенности СД2. Для получения репрезентативной выборки взрослые участники (в возрасте от 20 до 79 лет) были стратифицированы по возрасту, полу, географическому местоположению и типу поселения. Набор участников осуществлялся в общественных местах, посещаемых большим количеством людей. Диагноз СД2 устанавливался на основании анализа уровня гликированного гемоглобина (HbA1c) (сахарный диабет: HbA1c≥6,5%; предиабет: 5,7&lt;HbA1c&lt;6,5%). Также осуществлялся сбор социально-демографических и антропометрических данных.</p></sec><sec><title>Результаты</title><p>Результаты. Были получены образцы крови 26 620 участников. В 5,4% случаев был установлен диагноз СД2 (ранее диагностированный: 2,5%; ранее не диагностированный: 2,9%); у 19,3% участников был диагностирован предиабет. Рост показателей распространенности СД2 имел место по мере увеличения возраста пациентов (до 70 лет), заболевание встречалось с одинаковой частотой у женщин и у мужчин, 5,6% и 5,1% соответственно. Доля пациентов с предиабетом и СД2 была выше по мере увеличения индекса массы тела. Распространенность СД2 была выше среди жителей сельских поселений по сравнению с городским населением (6,7% по сравнению с 5,0%, p&lt;0,001).</p></sec><sec><title>Выводы</title><p>Выводы. Среди взрослого населения России 20–79 лет у 19,3% наблюдался предиабет, у 5,4% населения отмечено наличие СД2; у 54% пациентов заболевание ранее не было диагностировано. Полученные результаты призваны стать основой для разработки новой национальной программы профилактики и лечения СД2 в России. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To estimate the prevalence of type 2 diabetes mellitus (T2DM) in Russian adults.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. NATION was a national, epidemiological, observational, cross-sectional study. The sample of adults (20–79 years old) was stratified by age, sex, geographic region and settlement type to obtain a representative sample. Recruitment was performed in public areas with large number of people. T2DM was diagnosed by glycated haemoglobin A1c (HbA1c) levels (diabetes: HbA1c≥6.5%; pre-diabetes: HbA1c≥5.7% to &lt;6.5%). Socio-demographic and anthropometric data were collected.</p></sec><sec><title>Results</title><p>Results. Blood samples from 26,620 subjects were available. Overall, 5.4% were diagnosed with T2DM (2.5% were previously diagnosed and 2.9% were previously undiagnosed); 19.3% were pre-diabetic. T2DM prevalence increased with age (up to 70 years), and no significant difference was revealed between females and males (5.6% vs. 5.1%). The estimated prevalence of pre-diabetes and T2DM tended to increase with increasing BMI. T2DM prevalence varied by geographic region and was higher in rural areas than in urban areas (6.7% vs. 5.0%, p &lt; 0.001).</p></sec><sec><title>Conclusion</title><p>Conclusion. Approximately one in five adult Russians had pre-diabetes, 5.4% had T2DM and about half of the diabetic subjects were previously undiagnosed. These results demonstrate the need for new programs in the Russian Federation to predict, prevent and manage T2DM.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 2 типа</kwd><kwd>эпидемиологическое исследование</kwd><kwd>недиагностированный сахарный диабет</kwd><kwd>распространенность</kwd><kwd>Российская Федерация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>type 2</kwd><kwd>epidemiological study</kwd><kwd>undiagnosed diabetes mellitus</kwd><kwd>prevalence</kwd><kwd>Russian Federation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-321. doi: 10.1016/j.diabres.2011.10.029</mixed-citation><mixed-citation xml:lang="en">Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-321. doi: 10.1016/j.diabres.2011.10.029</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">IDF atlas (7th edition update). Brussels, Belgium. International Diabetes Federation; 2015. Available from: http://www.diabetesatlas.org/</mixed-citation><mixed-citation xml:lang="en">IDF atlas (7th edition update). Brussels, Belgium. International Diabetes Federation; 2015. Available from: http://www.diabetesatlas.org/</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Сунцов Ю.И., и др. Результаты реализации подпрограммы «Сахарный диабет» Федеральной целевой программы «Предупреждение и борьба с социально значимыми заболеваниями 2007-2012 годы» // Сахарный диабет. – 2013. – Т. 16. – №2S – C. 1-48. [Dedov II, Shestakova MV, Suntsov YI, et al. Federal targeted programme ‘Prevention and Management of Socially Significant Diseases (2007-2012): results of the ‘Diabetes mellitus’ sub-programme. Diabetes mellitus. 2013;16(2S):1-48. (in Russ)] doi: 10.14341/2072-0351-3879</mixed-citation><mixed-citation xml:lang="en">Дедов И.И., Шестакова М.В., Сунцов Ю.И., и др. Результаты реализации подпрограммы «Сахарный диабет» Федеральной целевой программы «Предупреждение и борьба с социально значимыми заболеваниями 2007-2012 годы» // Сахарный диабет. – 2013. – Т. 16. – №2S – C. 1-48. [Dedov II, Shestakova MV, Suntsov YI, et al. Federal targeted programme ‘Prevention and Management of Socially Significant Diseases (2007-2012): results of the ‘Diabetes mellitus’ sub-programme. Diabetes mellitus. 2013;16(2S):1-48. (in Russ)] doi: 10.14341/2072-0351-3879</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sidorenkov O, Nilssen O, Brenn T, et al. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Public Health. 2010;10:23. doi: 10.1186/1471-2458-10-23</mixed-citation><mixed-citation xml:lang="en">Sidorenkov O, Nilssen O, Brenn T, et al. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Public Health. 2010;10:23. doi: 10.1186/1471-2458-10-23</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Diabetes in Russia: Problems and Solutions. http://www.novonordisk.com/content/dam/Denmark/HQ/aboutus/documents/Russia%20II.pdf last accessed 16 December 2015.</mixed-citation><mixed-citation xml:lang="en">Diabetes in Russia: Problems and Solutions. http://www.novonordisk.com/content/dam/Denmark/HQ/aboutus/documents/Russia%20II.pdf last accessed 16 December 2015.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sanofi press-release, 28 February 2013. Available from: http://www.remedium.ru/news/detail.php?ID=55850</mixed-citation><mixed-citation xml:lang="en">Sanofi press-release, 28 February 2013. Available from: http://www.remedium.ru/news/detail.php?ID=55850</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Federal State Statistics Service. The final results of the National Population Census 2010. Available from: http://www.gks.ru/free_doc/new_site/perepis2010/croc/pere pis_itogi1612. htm</mixed-citation><mixed-citation xml:lang="en">Federal State Statistics Service. The final results of the National Population Census 2010. Available from: http://www.gks.ru/free_doc/new_site/perepis2010/croc/pere pis_itogi1612. htm</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Declaration of Helsinki. 1964, Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, and the 35th World Medical Assembly, Venice, Italy, October 1983.</mixed-citation><mixed-citation xml:lang="en">Declaration of Helsinki. 1964, Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, and the 35th World Medical Assembly, Venice, Italy, October 1983.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">ISPE. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf. 2008;17(2):200-208. doi: 10.1002/pds.1471</mixed-citation><mixed-citation xml:lang="en">ISPE. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf. 2008;17(2):200-208. doi: 10.1002/pds.1471</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Doelman CJ, Siebelder CW, Nijhof WA, et al. Capillary electrophoresis system for haemoglobinA1c determinations evaluated. ClinChem. 1997;644–648.</mixed-citation><mixed-citation xml:lang="en">Doelman CJ, Siebelder CW, Nijhof WA, et al. Capillary electrophoresis system for haemoglobinA1c determinations evaluated. ClinChem. 1997;644–648.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Menke A, Casagrande S, Geiss L, et al. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015;314(10):1021-1029. doi: 10.1001/jama.2015.10029</mixed-citation><mixed-citation xml:lang="en">Menke A, Casagrande S, Geiss L, et al. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015;314(10):1021-1029. doi: 10.1001/jama.2015.10029</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-322. doi: 10.1161/CIR.0000000000000152</mixed-citation><mixed-citation xml:lang="en">Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-322. doi: 10.1161/CIR.0000000000000152</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gyberg V, De Bacquer D, De Backer G, et al. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology. Cardiovasc Diabetol. 2015;14:133. doi: 10.1186/s12933-015-0296-y</mixed-citation><mixed-citation xml:lang="en">Gyberg V, De Bacquer D, De Backer G, et al. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology. Cardiovasc Diabetol. 2015;14:133. doi: 10.1186/s12933-015-0296-y</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Singh GM, Danaei G, Farzadfar F, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8(7):e65174. doi: 10.1371/journal.pone.0065174</mixed-citation><mixed-citation xml:lang="en">Singh GM, Danaei G, Farzadfar F, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8(7):e65174. doi: 10.1371/journal.pone.0065174</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wandell PE, Carlsson AC. Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden--a model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract. 2014;106(3):e90-92. doi: 10.1016/j.diabres.2014.09.013</mixed-citation><mixed-citation xml:lang="en">Wandell PE, Carlsson AC. Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden--a model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract. 2014;106(3):e90-92. doi: 10.1016/j.diabres.2014.09.013</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sattar N. Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Pract Res Clin Endocrinol Metab. 2013;27(4):501-507. doi: 10.1016/j.beem.2013.05.006</mixed-citation><mixed-citation xml:lang="en">Sattar N. Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Pract Res Clin Endocrinol Metab. 2013;27(4):501-507. doi: 10.1016/j.beem.2013.05.006</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2950-2959. doi: 10.1093/eurheartj/ehu299</mixed-citation><mixed-citation xml:lang="en">Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2950-2959. doi: 10.1093/eurheartj/ehu299</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Petrukhin IS, Lunina EY. Cardiovascular disease risk factors and mortality in Russia: challenges and barriers. Public Health Reviews. 2012;(33):436–449.</mixed-citation><mixed-citation xml:lang="en">Petrukhin IS, Lunina EY. Cardiovascular disease risk factors and mortality in Russia: challenges and barriers. Public Health Reviews. 2012;(33):436–449.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Grigoriev P, Meslé F, Shkolnikov VM, et al. The Recent Mortality Decline in Russia: Beginning of the Cardiovascular Revolution? Population and Development Review. 2014;40(1):107-129. doi: 10.1111/j.1728-4457.2014.00652.x</mixed-citation><mixed-citation xml:lang="en">Grigoriev P, Meslé F, Shkolnikov VM, et al. The Recent Mortality Decline in Russia: Beginning of the Cardiovascular Revolution? Population and Development Review. 2014;40(1):107-129. doi: 10.1111/j.1728-4457.2014.00652.x</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sattar N, Gill JM. Type 2 diabetes as a disease of ectopic fat? BMC Med. 2014;12:123. doi: 10.1186/s12916-014-0123-4</mixed-citation><mixed-citation xml:lang="en">Sattar N, Gill JM. Type 2 diabetes as a disease of ectopic fat? BMC Med. 2014;12:123. doi: 10.1186/s12916-014-0123-4</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gavrilova NS, Gavrilov LA. Rapidly Aging Populations: Russia/Eastern Europe. 2009:113-131. doi: 10.1007/978-1-4020-8356-3_6</mixed-citation><mixed-citation xml:lang="en">Gavrilova NS, Gavrilov LA. Rapidly Aging Populations: Russia/Eastern Europe. 2009:113-131. doi: 10.1007/978-1-4020-8356-3_6</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">English E, Idris I, Smith G, et al. The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review. Diabetologia. 2015;58(7):1409-1421. doi: 10.1007/s00125-015-3599-3</mixed-citation><mixed-citation xml:lang="en">English E, Idris I, Smith G, et al. The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review. Diabetologia. 2015;58(7):1409-1421. doi: 10.1007/s00125-015-3599-3</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Jaisson S, Pietrement C, Gillery P. Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Clin Chem. 2011;57(11):1499-1505. doi: 10.1373/clinchem.2011.163188</mixed-citation><mixed-citation xml:lang="en">Jaisson S, Pietrement C, Gillery P. Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Clin Chem. 2011;57(11):1499-1505. doi: 10.1373/clinchem.2011.163188</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hage C, Lundman P, Ryden L, et al. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes. Eur J Prev Cardiol. 2013;20(4):549-554. doi: 10.1177/2047487312444371</mixed-citation><mixed-citation xml:lang="en">Hage C, Lundman P, Ryden L, et al. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes. Eur J Prev Cardiol. 2013;20(4):549-554. doi: 10.1177/2047487312444371</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Farhan S, Jarai R, Tentzeris I, et al. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease. Clin Res Cardiol. 2012;101(8):625-630. doi: 10.1007/s00392-012-0435-3</mixed-citation><mixed-citation xml:lang="en">Farhan S, Jarai R, Tentzeris I, et al. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease. Clin Res Cardiol. 2012;101(8):625-630. doi: 10.1007/s00392-012-0435-3</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mo M, Zhong W, Zhao G, et al. Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults. BMC Endocr Disord. 2013;13:44. doi: 10.1186/1472-6823-13-44</mixed-citation><mixed-citation xml:lang="en">Mo M, Zhong W, Zhao G, et al. Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults. BMC Endocr Disord. 2013;13:44. doi: 10.1186/1472-6823-13-44</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Steylen PM, van der Heijden FM, Hoogendijk WJ, Verhoeven WM. Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study. Diabetes Metab Syndr Obes. 2015;8:57-63. doi: 10.2147/DMSO.S70029</mixed-citation><mixed-citation xml:lang="en">Steylen PM, van der Heijden FM, Hoogendijk WJ, Verhoeven WM. Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study. Diabetes Metab Syndr Obes. 2015;8:57-63. doi: 10.2147/DMSO.S70029</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Ageing 2013. ST/ESA/SER.A/348.</mixed-citation><mixed-citation xml:lang="en">United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Ageing 2013. ST/ESA/SER.A/348.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Gu K. Diabetes and Decline in Heart Disease Mortality in US Adults. JAMA. 1999;281(14):1291. doi: 10.1001/jama.281.14.1291.</mixed-citation><mixed-citation xml:lang="en">Gu K. Diabetes and Decline in Heart Disease Mortality in US Adults. JAMA. 1999;281(14):1291. doi: 10.1001/jama.281.14.1291.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497. doi: 10.1001/jama.285.19.2486</mixed-citation><mixed-citation xml:lang="en">Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497. doi: 10.1001/jama.285.19.2486</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
